Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Research prospects with benfluorex

D Ravel1, N Laudignon

  • 1Institut de Recherches Internationales Servier, Division Metabolisme, Courbevoie, France.

Journal of Diabetes and Its Complications
|September 1, 1996
PubMed
Summary

Benfluorex improves insulin sensitivity by reducing blood glucose and lipid levels in animal models. Its multifactorial action involves direct effects on tissues, hormone balance, and lipid availability, suggesting complex mechanisms for type II diabetes treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.

Translational psychiatry·2017
Same author

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders.

Translational psychiatry·2017
Same author

Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat.

The Journal of pharmacology and experimental therapeutics·2000
Same author

Effect of gliclazide treatment on insulin secretion and beta-cell mass in non-insulin dependent diabetic Goto-Kakisaki rats.

European journal of pharmacology·1998
Same author

Metabolic and anti-atherogenic effects of long-term benfluorex in dyslipidemic insulin-resistant sand rats (Psammomys obesus).

Life sciences·1998
Same author

Acute and chronic effects of dexfenfluramine on the porcine pulmonary artery.

General pharmacology·1998

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacology

Background:

  • Insulin resistance is linked to cardiovascular disease risk factors.
  • Agents improving insulin sensitivity are of significant interest.
  • Benfluorex (Médiator) is known to enhance insulin action.

Purpose of the Study:

  • To investigate the mechanism of action of benfluorex in improving insulin sensitivity.
  • To explore the potential of benfluorex in managing diabetes and insulin resistance.

Main Methods:

  • Chronic benfluorex treatment was administered to various genetic and dietary animal models of diabetes and insulin resistance.
  • Observed effects included changes in circulating insulin, blood glucose, triglycerides, and cholesterol concentrations.

Related Experiment Videos

Main Results:

  • Benfluorex treatment diminished circulating insulin levels.
  • Decreased blood glucose, triglyceride, and cholesterol concentrations were observed.
  • A multifactorial mode of action was postulated, involving effects on insulin target tissues, glucoregulatory hormone balance, and lipid availability.

Conclusions:

  • Benfluorex exhibits a complex, multifactorial mechanism of action.
  • The drug's effects involve direct action on insulin target tissues, modulation of neuroendocrine tone, and reduced lipid availability.
  • Further research is needed to identify molecular targets for insulin sensitizers like benfluorex in type II diabetes treatment.